XML 47 R34.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Summary of Option Activity | A summary of options activity under the Company’s stock option plan for the years ended December 31, 2025 and 2024 are presented below: Summary of Option Activity
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Options outstanding as of December 31, 2024 |  |  | 1,302,500 |  |  | $ | 1.96 |  |  | $ | 804,300 |  |  |  | 1.7 |
Employee options granted |  |  | 1,918,053 |  |  |  | 2.84 |  |  |  | 4,500 |  |  |  | 6.3 |
Employee options exercised |  |  | (1,100,000 | ) |  |  | 1.90 |  |  |  | - |  |  |  | - |
Employee options expired |  |  | (68,158 | ) |  |  | 2.47 |  |  |  | - |  |  |  | - |
Employee options forfeited |  |  | (50,000 | ) |  |  | 1.40 |  |  |  | - |  |  |  | - |
Options outstanding as of December 31, 2025 |  |  | 2,002,395 |  |  | $ | 2.84 |  |  | $ | 460,715 |  |  |  | 5.6 |
Options vested and exercisable as of December 31, 2025 |  |  | 1,338,910 |  |  | $ | 2.52 |  |  | $ | 298,490 |  |  |  | 5.8 |
Option exercises during fiscal year 2025 primarily related to cashless exercises of vested options, and option forfeitures and expirations reflect unvested and vested awards, respectively, that were cancelled in connection with employee departures in the ordinary course of business.
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Options outstanding as of December 31, 2023 |  |  | 1,200,000 |  |  | $ | 2.12 |  |  | $ | 8,700 |  |  |  | 2.4 |
Employee options granted |  |  | 120,000 |  |  |  | 1.52 |  |  |  | - |  |  |  | 4.6 |
Employee options expired |  |  | (17,500 | ) |  |  | 10.30 |  |  |  | - |  |  |  | - |
Options outstanding as of December 31, 2024 |  |  | 1,302,500 |  |  | $ | 1.96 |  |  | $ | 804,300 |  |  |  | 1.7 |
Options vested and exercisable as of December 31, 2024 |  |  | 1,141,250 |  |  | $ | 2.02 |  |  | $ | 649,125 |  |  |  | 1.3 |
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value | The fair value of market-based LTI RSUs is estimated using a Monte Carlo simulation. The following assumptions were used to determine fair value as of the January 1, 2023, modification date: Schedule of Weighted-Average Assumptions Used to Estimate Fair Value
|  | January 1, 2023 (Modification) |
Vesting Hurdle Price |  | $ | 3.81 - $30.52 |
Term (years) |  |  | 4.00 |
Expected stock price volatility |  |  | 97.30 | %
Risk-free rate of interest |  |  | 4.10 | %
Schedule of Restricted Stock Units | Schedule of Restricted Stock Units
| Market Cap Vesting Thresholds |
| $ 100 million |  |  |  | $ 150 million |  |  |  | $ 300 million |
| 50,000 |  |  |  | 50,000 |  |  |  | 50,000 |
Summary of Restricted Stock | The following table summarizes RSU activity under the 2021 Plan for the years ended December 31, 2025 and 2024: Summary of Restricted Stock
|  | Number of Restricted Stock Units |  |  | Weighted Average Grant Date Fair Value |
Nonvested as of December 31, 2023 |  |  | 1,606,373 |  |  | $ | 3.25 |
Granted |  |  | 300,000 |  |  |  | 1.71 |
Vested |  |  | (445,350 | ) |  |  | 3.13 |
Vested and converted to restricted common shares |  |  | (220,052 | ) |  |  | 2.01 |
Forfeited |  |  | (100,000 | ) |  |  | 1.63 |
Nonvested as of December 31, 2024 |  |  | 1,140,971 |  |  | $ | 3.27 |
Granted |  |  | 150,000 |  |  |  | 2.47 |
Vested |  |  | - |  |  |  | - |
Vested and converted to restricted common shares |  |  | (1,170,834 | ) |  |  | 3.05 |
Forfeited |  |  | (120,137 | ) |  |  | 4.37 |
Nonvested as of December 31, 2025 |  |  | - |  |  | $ | - |
Schedule of Stock-based Compensation Expense | Stock-based compensation expenses are recorded as a part of general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expenses for the years ended December 31, 2025 and 2024 were as follows: Schedule of Stock-based Compensation Expense
|  | 2025 |  |  | 2024 |
|  | For the Year Ended December 31, |
|  | 2025 |  |  | 2024 |
Employee stock option awards |  | $ | 605,070 |  |  | $ | 2,973,503 |
Employee restricted stock awards |  |  | 451,840 |  |  |  | 1,188,963 |
Forfeiture of employee restricted stock unit and share awards |  |  | (549,840 | ) |  |  | - |
Employee share-based salary payments |  |  | - |  |  |  | 1,176,679 |
Non-employee restricted stock awards |  |  | 150,006 |  |  |  | 165,011 |
Total stock-based compensation |  | $ | 657,076 |  |  | $ | 5,504,156 |
Summary of Warrant Activity | The following is a summary of warrant activity for the years ended December 31, 2025 and 2024: Summary of Warrant Activity
|  | Number of Warrants |
Outstanding as of December 31, 2023 |  |  | 712,500 |
Expiration of warrants |  |  | - |
Outstanding as of December 31, 2024 |  |  | 712,500 |
Issuance of warrants in connection with convertible note |  |  | 2,781,291 |
Exercised |  |  | (1,369,725 | )
Outstanding as of December 31, 2025 |  |  | 2,124,066 |
Common Stock [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Summary of Restricted Stock | The following table summarizes restricted Common Stock activity under the 2021 Plan for the years ended December 31, 2025 and 2024: Summary of Restricted Stock
|  | Number of Restricted Shares of Common Stock |
Outstanding and nonvested as of December 31, 2023 |  |  | - |
Converted from restricted stock units |  |  | 258,294 |
Granted |  |  | 12,500 |
Outstanding and nonvested as of December 31, 2024 |  |  | 270,794 |
Converted from restricted stock units |  |  | 1,170,834 |
Vested |  |  | (500,593 | )
Forfeited |  |  | (462,660 | )
Outstanding and nonvested as of December 31, 2025 |  |  | 478,375 |
Restricted Stock [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value | Schedule of Weighted-Average Assumptions Used to Estimate Fair Value
|  | January 1, 2025 |
Vesting Hurdle Price |  | $ | 5.26 - $15.79 |
Term (years) |  |  | 2.00 |
Expected stock price volatility |  |  | 92.70 | %
Risk-free rate of interest |  |  | 4.25 | %
2021 Equity Incentive Plan [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value | The following weighted-average assumptions were used to estimate the fair value of options granted during the years ended December 31, 2025 and 2024, using the Black-Scholes model: Schedule of Weighted-Average Assumptions Used to Estimate Fair Value
|  | For the Year Ended December 31, |
|  | 2025 |  |  | 2024 |
Exercise price |  | $ | 2.79 |  |  | $ | 1.52 |
Term (years) |  |  | 6.65 |  |  |  | 5.00 |
Expected stock price volatility |  |  | 115.79 | % |  |  | 141.86 | %
Risk-free rate of interest |  |  | 4.08 | % |  |  | 4.50 | %

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of employee stock purchase plan activity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 50 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718-50/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=BTCS_TwoThousandAndTwentyOneEquityIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |